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Introduction
Nitric oxide (NO•) produced by the constitutive form
of nitric oxide synthase plays a critical role in normal
physiology by regulating vasomotor tone (1, 2). The
larger amounts of NO• produced by the inducible iso-
form of the enzyme contribute to the ability of inflam-
matory cells to kill microbial organisms and tumor
cells. Under pathological conditions, however, reactive
nitrogen species derived from NO• may injure normal
tissue (3). The most widely studied mechanism involves
the rapid reaction of NO• with superoxide (4, 5) to pro-
duce peroxynitrite (ONOO–). In vitro, ONOO– yields
potent hydroxylating and nitrating species. Immuno-
histochemical studies suggest that ONOO– contributes
to a variety of pathological conditions, including ath-
erosclerosis, acute respiratory distress syndrome, and
ischemia/reperfusion injury (3, 5).
Evidence that ONOO– provides a mechan-
ism for oxidative damage rests largely on the de-
tection of 3-nitrotyrosine in inflamed tissue (3, 5). 
However, immunohistochemical approaches are only 
semiquantitative. Moreover, cross-reacting but struc-
turally distinct molecules may confound immunode-
tection. Many investigators have noted that artifact
formation complicates analysis of oxidation products,
and this has been a particular problem with 3-nitroty-
rosine (6–10). It is also unclear whether NO• and
superoxide produced at physiologically plausible rates
will nitrate tyrosine efficiently in vitro (11–13), leaving
open the possibility that 3-nitrotyrosine has a differ-
ent origin in vivo.
NO• can also autoxidize to nitrite (NO2–) and nitrate
(NO3–) (14). Plasma levels of NO2–, which range up to
4 µM in healthy humans, increase markedly during
acute and chronic inflammation (14). Because NO2–
is a substrate for myeloperoxidase, a heme enzyme
secreted by activated phagocytes, it might also be used
for tyrosine nitration in vivo (15). Indeed, myeloper-
oxidase uses hydrogen peroxide (H2O2) and NO2– to
generate reactive nitrogen species that nitrate tyrosyl
residues in vitro (16–18). These reactions might be
physiologically relevant because human neutrophils
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Despite intense interest in pathways that generate reactive nitrogen species, the physiologically relevant
mechanisms for inflammatory tissue injury remain poorly understood. One possible mediator is
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The enzyme uses hydrogen peroxide and nitrite to generate 3-nitrotyrosine in vitro. To determine whether
myeloperoxidase produces nitrating intermediates in vivo, we used isotope dilution gas chromatogra-
phy/mass spectrometry to quantify 3-nitrotyrosine in two models of peritoneal inflammation: mice
infected with Klebsiella pneumoniae and mice subjected to cecal ligation and puncture. Both models devel-
oped an intense neutrophil inflammatory response, and the inflammatory fluid contained markedly ele-
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levels rose only in the mice infected with K. pneumoniae. Levels of total nitrite and nitrate were 20-fold
higher in mice injected with K. pneumoniae than in mice subjected to cecal ligation and puncture. Levels
of 3-nitrotyrosine failed to increase in mice infected with K. pneumoniae that lacked functional myeloper-
oxidase. Our observations provide strong evidence that myeloperoxidase generates reactive nitrogen
species in vivo and that it operates in this fashion only when nitrite and nitrate become available.
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can use the myeloperoxidase-H2O2-NO2– system to
chlorinate and nitrate tyrosine analogues (17).
Despite intense interest in the role of reactive nitrogen
species in host defense mechanisms and oxidative tissue
injury, the in vivo pathways that promote nitration
remain poorly understood (1, 2). The difficulty of quan-
tifying nitrated tyrosine in biological samples has con-
tributed to the lack of progress (6–10). In the current
study, we use two clinically relevant models of sepsis and
gas chromatography/mass spectrometry (GC/MS) to
determine whether myeloperoxidase generates 3-nitroty-
rosine in vivo (19). Mass spectrometry has the major
advantage of being a quantitative method that permits
the use of isotopomers for monitoring any analyte that
forms ex vivo during sample work-up and analysis. Our
experiments using this method provide strong evidence
that myeloperoxidase generates nitrating oxidants in
vivo, possibly by a pathway involving NO2–.
Methods
General procedures. Myeloperoxidase was purified from
HL60 cells (20, 21). Total NO2– and NO3– was quanti-
fied in peritoneal fluid using the Griess reagent (Cay-
man Chemical, Ann Arbor, Michigan, USA).
Animals. The Animal Studies Committee of Washing-
ton University School of Medicine in St. Louis approved
all animal studies. Mice were maintained under
pathogen-free conditions on a 12-hour light/dark
schedule. Myeloperoxidase-deficient mice were gener-
ated in a 129/SvJ background; they were backcrossed at
least four generations into the C57BL/6J background
(The Jackson Laboratory, Bar Harbor, Maine, USA)
prior to use (22). Experiments were performed with age-
matched (8–16 weeks) and sex-matched C57BL/6J mice.
Reaction conditions. Reactions were carried out for 60
minutes at 37°C in Chelex-treated (Bio-Rad, Hercules,
California, USA) buffer A (100 mM NaCl, 50 mM sodi-
um phosphate, 100 µM diethylenetriaminepentaacetic
acid, pH 7.4) supplemented with 0.5 mM N-acetyl-L-
tyrosine. Reactions were initiated by adding H2O2 or
HOCl and terminated with 0.1 mM methionine and
200 nM catalase.
Reverse-phase HPLC analysis. Analyses were performed
using a flow rate of 1 ml/min and an Ultrasphere ODS
reverse-phase column (4.6 mm × 25 cm; 5 µm resin;
Beckman Instruments Inc., Fullerton, California, USA)
as described (10, 23).
Bacterial killing. The bactericidal activity of myeloper-
oxidase was quantified as described (24). Briefly, Kleb-
siella pneumoniae were incubated alone or with 5 nM
enzyme, 5 nM H2O2, in 0.5 mM NaOAc buffer (pH 5.0
or pH 7.0) for 1 hour at 37°C with 0.1 mM or 10 mM
NaNO2 and/or 100 mM Cl–. Serial dilutions were
immediately spread on agar plates, and the CFUs were
determined after overnight incubation at 37°C.
Immunostaining of mouse neutrophils. Mouse neutrophils
were elicited by intraperitoneal injection of 1 ml of ster-
ile 15% glycogen in PBS (pH 7.4). Four hours after injec-
tion, the cells were harvested by intraperitoneal lavage,
contaminating red blood cells were lysed, and the neu-
trophils were washed three times with PBS (pH 7.4) (24).
Neutrophils were incubated with K. pneumoniae (24) in
the presence or absence of 100 µM NO2– for 1 hour at
37°C. Neutrophils were then washed three times with
PBS, trypsinized, and cytospun onto slides. Cells were
immunostained for nitrotyrosine using a rabbit poly-
clonal anti-nitrotyrosine antibody (Upstate Inc., Lake
Placid, New York, USA) and a biotinylated goat anti-rab-
bit IgG secondary antibody according to the manufac-
turer (Vector Laboratories Inc., Burlingame, California,
USA). Cells were immunostained for inducible nitric
oxide synthase using a goat monoclonal anti–inducible
nitric oxide synthase antibody (Santa Cruz Biotechnol-
ogy Inc., Santa Cruz, California, USA) followed by a
biotinylated rabbit anti-goat IgG antibody as described
by the manufacturer (Vector Laboratories Inc.).
Sepsis models. Cecal ligation and puncture (CLP) was
performed as described (23). Mice were injected
intraperitoneally with 4 × 108 K. pneumoniae. The peri-
toneum was lavaged 16 hours after injection with 10 ml
of PBS. Lavage fluid was stored at –80°C until analysis.
Cell analysis. Cells were placed onto slides by centrifuga-
tion and stained with a modified Wright’s stain (Dimscio
and Associates, Manchester, Missouri, USA). Cell counts
were performed by the Department of Comparative Med-
icine at Washington University School of Medicine.
Western blotting, immunoprecipitation, and protein identifi-
cation. K. pneumoniae (108/ml) were incubated with 5 nM
myeloperoxidase, 100 µM H2O2, and 100 µM or 500 µM
NO2– for 1 hour at 37°C. Bacteria were pelleted by cen-
trifugation and incubated with 4 mg/ml lysozyme, 50
mM glucose, 10 mM EDTA, and 25 mM Tris (pH 8) for
5 minutes. The pellet was incubated with lysis buffer
(150 mM NaCl, 1% NP-40, 0.1% SDS, 50 mM Tris, pH 8)
on ice for 30 minutes and centrifuged, and soluble pro-
teins were subjected to SDS-PAGE. The separated pro-
teins were transferred to a nitrocellulose membrane
(preincubated with 5% milk and 0.05% Tween-20 in PBS)
and probed with a rabbit polyclonal anti-nitrotyrosine
antibody (Upstate Inc.) followed by a goat anti-rabbit Ig
antibody (Santa Cruz Biotechnology Inc.) conjugated to
horseradish peroxidase. Immunoreactive proteins were
visualized using West Pico chemiluminescent substrate
(Pierce Chemical Co., Rockford, Illinois, USA). Proteins
were immunoprecipitated with mouse monoclonal anti-
nitrotyrosine antibody coupled to agarose beads
(Upstate Inc.), eluted with 4× Novex loading buffer
(Invitrogen Corp., San Diego, California, USA), and sub-
jected to SDS-PAGE. Protein bands were stained, excised
from the gel, digested in situ with trypsin, and subjected
to liquid chromatography–quadrupole time-of-flight
mass spectrometry (25).
GC/MS analysis. Samples were prepared and analyzed
in the negative ion electron capture mode as described
previously (10, 23). Amino acids were isolated from
peritoneal fluid by solid-phase extraction following the
addition of internal standards (L-3-nitro[13C6]tyrosine,
L-[13C6]tyrosine, L-[13C9, 15N]tyrosine). 3-Nitrotyrosine
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was derivatized and quantified using the ion at mass-
to-charge ratio (m/z) 518 ([M-O-t-butyl-dimethylsilyl]–)
and the ion derived from the isotopically labeled [13C6]-
internal standard (m/z 524). Potential artifact forma-
tion during sample work-up was monitored as the
appearance of ion current at m/z 528 derived from 
L-[13C9, 15N]tyrosine. 3-Nitrotyrosine measurements
were corrected for the minimal quantities of product
that sometimes formed during sample preparation. 
L-tyrosine was quantified using the ion at m/z 407 
([M-COO-t-butyl-dimethylsilyl]–) and the ion derived
from L-[13C9, 15N]tyrosine at m/z 416.
Statistical analysis. The strength of the statistical differ-
ences between pairs of groups was evaluated using the
Student’s t test. Significance was accepted at P < 0.05.
Results
Myeloperoxidase generates N-acetyl-3-nitrotyrosine in vitro
under physiologically relevant conditions. Previous studies
have used the tyrosine analogue 4-hydroxyphenylacetic
acid to investigate the production of reactive nitrogen
species by myeloperoxidase in vitro (17, 18). To confirm
that myeloperoxidase can nitrate tyrosine, we incubat-
ed the enzyme (5 nM) with NO2– (100 µM), N-acetyl-L-
tyrosine (0.5 mM), H2O2 (50 µM), and plasma concen-
trations of chloride ion (Cl–; 100 mM) in phosphate
buffer at neutral pH. N-acetyl-L-tyrosine was used
instead of L-tyrosine itself to prevent the production of
chloramines and p-hydroxyphenylacetaldehyde (26).
Reverse-phase HPLC analysis of the reaction mixture
revealed three peaks of new material (peaks I–III, Figure
1a). Peak III contained the only product whose forma-
tion required the complete system (Figure 1a). The reten-
tion time and absorption spectrum of that product were
identical to those of authentic N-acetyl-3-nitrotyrosine
(Figure 1a, inset). In contrast, generation of peaks I and
II required myeloperoxidase and H2O2 but not NO2–.
Tandem mass spectrometric analysis in the negative ion
mode (27) demonstrated spectra that were consistent
with N-acetyl-o,o′-dityrosine (peak I, data not shown), N-
acetyl-3-chlorotyrosine (peak II, data not shown), and N-
acetyl-3-nitrotyrosine (peak III, Figure 1b). The identity
of peak III as N-acetyl-3-nitrotyrosine was confirmed
with high-resolution proton nuclear magnetic resonance
spectroscopy (Figure 1c). Significant features included
loss of the C-3 proton resonance, a downfield shift in the
C-2 proton, and conversion of the C-2 proton resonance
from a doublet to a singlet.
Formation of N-acetyl-3-nitrotyrosine required NO2–,
N-acetyl-L-tyrosine, H2O2, and myeloperoxidase. The
reaction depended linearly on NO2– concentration over
a physiologic range (1–100 µM) and was complete in
less than 10 minutes. It was inhibited by about 20% by
plasma concentrations of Cl– and was also inhibited by
the peroxide scavenger catalase and the heme poison
sodium azide. These results indicate that myeloperox-
idase nitrates N-acetyl-L-tyrosine by a reaction that
requires active enzyme, NO2–, and H2O2, and that 
N-acetyl-3-nitrotyrosine is the major stable product.
Myeloperoxidase generates N-acetyl-3-nitrotyrosine by direct-
ly oxidizing NO2–. It has been proposed that myeloperox-
idase uses two distinct pathways to generate reactive
nitrogen species (16–18, 28, 29). In the first pathway, the
enzyme generates HOCl, using H2O2 and Cl– (Equation
1 below) (30–32). The HOCl then reacts with NO2– to
form nitryl chloride, a nitrating species (Equation 2). In
the second pathway, myeloperoxidase uses a one-elec-
tron reaction to directly oxidize NO2– to nitrogen diox-
ide radical, NO2• (Equation 3). NO2• then might direct-
ly oxidize tyrosine, or it might react with the tyrosyl




To distinguish between these two pathways, we first
compared the effect of pH on the ability of either a mix-
ture of reagent HOCl and NO2– or the myeloperoxidase-
H2O2-NO2–-Cl– system to generate N-acetyl-3-nitroty-
rosine. Interestingly, the HOCl-NO2– system operated
optimally at neutral pH, whereas the enzymatic system
had an acidic pH optimum (Figure 2, a and b). This dif-
ference suggests that myeloperoxidase might be able to
nitrate N-acetyl-L-tyrosine by a mechanism not involv-
ing HOCl. Alternatively, myeloperoxidase might gener-
ate HOCl most efficiently under acidic conditions.
We next determined whether taurine (2-aminoethane-
sulfonic acid, a potent scavenger of HOCl) (31, 34),
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Figure 1
Analysis of N-acetyl-L-tyrosine exposed to the myeloperoxidase-NO2–-
Cl–-H2O2 system. (a) HPLC analysis. Inset: Absorbance spectra of
authentic N-acetyl-L-3-nitrotyrosine (N-Ac-nitrotyrosine [N-Ac-NO2-Y])
and peak III. (b) Electrospray ionization tandem mass spectrometric
analysis of peak III. (c) Aromatic region of a proton nuclear magnetic
resonance spectrum of peak III. MPO, myeloperoxidase.
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inhibited nitration by the HOCl-NO2– mixture or the
enzymatic system. Increasing concentrations of taurine
progressively inhibited the conversion of N-acetyl-L-
tyrosine to N-acetyl-3-nitrotyrosine by HOCl-NO2– at
neutral pH (Figure 2c). In marked contrast, taurine had
no effect when myeloperoxidase nitrated N-acetyl-L-
tyrosine. This result provides strong evidence that
myeloperoxidase nitrates N-acetyl-L-tyrosine by a path-
way not involving HOCl. The pathway likely involves
direct oxidation of NO2– by compound I (Equation 3)
and the reaction of NO2• with tyrosyl radical. It is note-
worthy that myeloperoxidase preferentially oxidizes
NO2– under these conditions, despite the presence of
2000-fold greater levels of Cl–.
Myeloperoxidase uses NO2– and H2O2 to generate bacterici-
dal oxidants. Because myeloperoxidase-deficient mice
are more vulnerable to infection with the Gram-nega-
tive bacterium K. pneumoniae than are wild-type mice
(our unpublished observation), we determined how
NO2–, Cl–, and myeloperoxidase affect the killing of K.
pneumoniae under neutral and acidic conditions (24).
When the myeloperoxidase-H2O2 system in phosphate
buffer at pH 7 was supplemented with physiologically
plausible concentrations of NO2– (0.1 mM) or Cl– (100
mM), it killed about 70% of the bacteria in the reaction
mixture. Similar results were observed when both NO2–
and Cl– were included. Peroxide alone failed to kill bac-
teria under these conditions.
Different results were observed at pH 5. The
myeloperoxidase-H2O2 system supplemented with 100
mM Cl– killed essentially all of the bacteria. In contrast,
only 82% of the bacteria were killed when the reaction
mixture included NO2– at a level (10 mM) 100-fold
higher than that observed in plasma during inflam-
mation. These observations indicate that the bacterici-
dal activity of the myeloperoxidase-H2O2-NO2– system
depends critically on the pH of the reaction mixture.
Klebanoff reported that killing of Escherichia coli showed
a similar pH dependency (15).
Myeloperoxidase nitrates bacterial proteins in vitro. To
explore the potential contribution of protein nitration
to the cytotoxic activity of the myeloperoxidase-H2O2-
NO2– system, we used a polyclonal antibody to nitroty-
rosine to search for bacterial proteins that become
nitrated in vitro. After exposing K. pneumoniae to
myeloperoxidase, H2O2, and NO2– (Figure 3a), we
observed multiple bands of immunoreactive material
in bacterial proteins subjected to SDS-PAGE and West-
ern blotting. A protein of about 65 kDa was particu-
larly prominent (Figure 3a). Protein nitration required
both myeloperoxidase and NO2– (Figure 3a).
To identify the nitrated proteins, bacterial proteins
were immunoprecipitated with a mouse monoclonal
anti-nitrotyrosine antibody. When the isolated material
was separated using SDS-PAGE, protein staining
revealed four major bands (Figure 3b). Once again, a pro-
tein of about 65 kDa was particularly prominent. When
the isolated material was subjected to Western blot
analysis with the polyclonal anti-nitrotyrosine antibody,
the only immunoreactive band was again the approxi-
mately 65-kDa protein (data not shown). Tandem mass
spectrometric analysis of trypsin digests of the isolated
protein identified the sequence VLVNTKATLAAFR (Fig-
ure 3c), a peptidyl aspartic acid metalloendopeptidase of
the bacterium Pseudomonas fragi. This sequence is not
present in any known K. pneumoniae protein, but the
complete genomic sequence of this organism is not avail-
able. These observations raise the possibility that reac-
tive nitrogen species generated by myeloperoxidase con-
tribute to bacterial killing by oxidizing specific protein
targets such as metalloproteinases.
Depriving neutrophils of myeloperoxidase impairs their abil-
ity to nitrate cytoplasmic proteins. To determine whether
nitration of tyrosine by myeloperoxidase might be phys-
iologically relevant, we isolated neutrophils from wild-
type and myeloperoxidase-deficient mice. We then incu-
bated the cells with K. pneumoniae, a major cause of
sepsis in humans, in the presence (100 µM) or absence
of NO2–. One hour after infection, the neutrophils were
immunostained with an anti–3-nitrotyrosine antibody.
In the presence of NO2–, the wild-type cells showed dis-
tinct cytoplasmic immunostaining (Figure 4a). A simi-
lar pattern of immunoreactivity was observed in the
absence of NO2– (Figure 4b), but the immunostaining
was less intense. In contrast, no immunostaining was
observed in the cells that lacked functional myeloper-
oxidase in the presence (Figure 4c) or absence of NO2–
(data not shown). Omitting the primary antibody or
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Figure 2
Reaction requirements for generation of N-Ac-nitrotyrosine by HOCl and myeloperoxidase. (a and b) Effect of pH. (c) Effect of taurine.
Results represent means ± SEM of three independent experiments.
Downloaded on June  3, 2013.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/15021
preincubating the 3-nitrotyrosine antibody with 10 mM
of 3-nitrotyrosine also prevented immunostaining of
wild-type cells (data not shown). Because we observed
immunoreactivity for 3-nitrotyrosine in the absence of
NO2–, we hypothesized that mouse neutrophils gener-
ate NO• after they are activated by K. pneumoniae (24,
35). Indeed, both wild-type and myeloperoxidase-defi-
cient cells immunostained intensely for the inducible
form of nitric oxide synthase (Figure 4, d–f). These
results suggest that mouse neutrophils use myeloper-
oxidase to nitrate cytoplasmic proteins.
Free 3-nitrotyrosine is detectable in peritoneal fluid isolated
from septic mice. To determine whether tyrosine is nitrated
in vivo during inflammation, peritoneal fluid from sep-
tic mice was analyzed by isotope dilution GC/MS. We
were aware that ex vivo formation of 3-nitrotyrosine can
be a major problem during analysis of biological materi-
als (6, 7, 9, 10). Indeed, some studies have suggested that
virtually all of the 3-nitrotyrosine detected in plasma and
tissue is generated artifactually (6, 7, 9). To circumvent
this problem, we used a method that avoids strongly
acidic conditions during sample preparation and amino
acid derivatization (7, 10, 23). To confirm that any 
3-nitrotyrosine detected in inflammatory fluid was
endogenous rather than artifactual, an isotope-labeled
tyrosine (L-[13C9, 15N]tyrosine) was routinely added to
each sample before analysis. We reasoned that any proce-
dure that converted endogenous tyrosine to 3-nitrotyro-
sine would also convert L-[13C9, 15N]tyrosine to 
3-nitro[13C9, 15N]tyrosine. The latter would be detectable
by GC/MS because its m/z differs from those of 3-nitroty-
rosine and the internal standard. Thus, its appearance
would indicate that artifactual oxidation had taken place.
To determine whether L-tyrosine is nitrated during
sepsis, the peritonea of wild-type mice were infected
with K. pneumoniae. Sixteen hours later, the peritoneum
was lavaged to obtain fluid containing white blood
cells, bacteria, and inflammatory exudate. This lavage
fluid was immediately frozen and stored at –80°C. For
analysis, the fluid was thawed and centrifuged, and the
supernatant was harvested. Less than 3% of the free
tyrosine in the lavage fluid remained in the cellular pel-
let, demonstrating that free tyrosine from both the cel-
lular and extracellular components of peritoneal lavage
fluid was recovered quantitatively by this procedure.
Isotope dilution GC/MS was used to quantify free 
3-nitrotyrosine in the supernatant (7, 10, 23). The deriva-
tized material contained a compound that exhibited the
major ion and retention time identical to those of
authentic 3-nitrotyrosine. Selected ion monitoring
showed that the ion derived from the amino acid (Figure
5a) co-eluted with the ion derived from 13C-labeled inter-
nal standard (3-nitro[13C6]tyrosine; Figure 5b). In con-
trast, there was little evidence for 3-nitrotyrosine forma-
tion during sample work-up and analysis (3-nitro[13C9,
15N]tyrosine; Figure 5c). These observations indicate that
free 3-nitrotyrosine is detectable in peritoneal lavage
fluid from mice infected with K. pneumoniae and that the
compound is not generated ex vivo during analysis.
Myeloperoxidase generates 3-nitrotyrosine during acute
inflammation. To determine whether myeloperoxidase
could have generated the 3-nitrotyrosine observed in
peritoneal fluid, we investigated 3-nitrotyrosine for-
mation in two models of acute inflammation charac-
terized by an intense neutrophil response (23, 24).
The first model (described above) employed the
intraperitoneal injection of K. pneumoniae. Neu-
trophils were the predominant cells in lavage fluid
from both the wild-type animals (n = 3; 97% ± 1% neu-
trophils, 1% ± 0% macrophages, 2% ± 1% eosinophils)
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Figure 3
Western blot analysis and immunoprecipitation of K. pneumoniae pro-
teins exposed to the myeloperoxidase-H2O2-NO2– system at neutral
PH. (a) Western blot analysis of nitrated proteins isolated from a
reaction mixture containing K. pneumoniae (KP), myeloperoxidase,
H2O2, and NO2– (100 or 500 µM). Proteins were probed with a rab-
bit polyclonal antibody to 3-nitrotyrosine. (b) Solubilized proteins
from K. pneumoniae exposed to myeloperoxidase, H2O2, and NO2–
were immunoprecipitated with a mouse mAb to 3-nitrotyrosine.
Only the protein of about 65 kDa was immunoreactive with a rabbit
polyclonal antibody to 3-nitrotyrosine. (c) Tandem mass spectro-
metric analysis of a trypsin digest of the immunoreactive 65-kDa pro-
tein. (M+H)+, molecular ion.
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and the myeloperoxidase-deficient animals (n = 3; 
96% ± 1% neutrophils, 2% ± 1% macrophages, 3% ± 2%
eosinophils). Occasional red blood cells and abundant
intracellular and extracellular microorganisms were
also apparent. Importantly, the cellular response to
sepsis of the myeloperoxidase-deficient animals was
comparable to that of the wild-type animals.
The second model was a clinically relevant mouse
model that creates sepsis through cecal ligation and
puncture (CLP), which allows intestinal bacteria to leak
into the peritoneum. Neutrophils predominate in the
lavage fluid, and myeloperoxidase deficiency does not
affect their abundance (23). However, the peritoneal
inflammatory fluid contains more red blood cells and
cellular debris than does lavage fluid from mice infect-
ed with K. pneumoniae.
Peritoneal lavage fluid from wild-type mice subjected
to either CLP or infection with K. pneumonia had
markedly higher levels of immunoreactive myeloper-
oxidase than did peritoneal lavage fluid from control
mice. In contrast, peritoneal fluid isolated from the
septic myeloperoxidase-deficient mice contained no
immunoreactive protein. We have previously shown
that myeloperoxidase-deficient mice produce active
eosinophil peroxidase (23). These results indicate that
the number of myeloperoxidase-containing cells
increases markedly in the normal mouse
peritoneum during sepsis, that myeloperox-
idase-deficient mice lack immunoreactive
myeloperoxidase, and that both the wild-
type mice and the genetically altered mice
make eosinophil peroxidase.
Previous studies have demonstrated that
neutrophils employ myeloperoxidase to gen-
erate chlorinating intermediates in vivo (23). Consis-
tent with these observations, we detected a marked
increase in levels of 3-chlorotyrosine in both models of
inflammation (Figure 6a). This increase was almost
completely abrogated in myeloperoxidase-deficient
mice. To determine whether myeloperoxidase similarly
generates nitrating species in vivo, 3-nitrotyrosine lev-
els were quantified by isotope dilution GC/MS (Figure
6b). In this analysis, we observed a striking difference
between the two models. Peritoneal lavage fluid from
wild-type mice and myeloperoxidase-deficient mice
subjected to CLP contained similar levels of 3-nitroty-
rosine (Figure 6b). However, the level of 3-nitrotyrosine
in lavage fluid from wild-type mice infected with K.
pneumoniae was 2.5-fold higher than the level in fluid
from myeloperoxidase-deficient animals (Figure 6b) 
(P < 0.01). The latter was similar to the levels observed
after wild-type mice and myeloperoxidase-deficient
mice were subjected to CLP. Collectively, these results
indicate that a myeloperoxidase-dependent pathway
nitrates tyrosine during the acute inflammation that
follows K. pneumoniae infection but not during the tyro-
sine nitration that occurs after CLP.
K. pneumoniae infection markedly increases NO2– and
NO3– levels. Myeloperoxidase generates reactive nitro-
gen species in vitro by a reaction pathway that
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Figure 5
Detection of free 3-nitrotyrosine in peritoneal inflammatory exudate of a wild-type mouse infected with K. pneumoniae. Amino acids were iso-
lated from peritoneal fluid by solid-phase chromatography, converted to their heptafluobutyryl t-butyl-dimethylsilyl derivatives, and sub-
jected to GC/MS analysis. (a) Endogenous (m/z 518), (b) isotope-labeled (m/z 524), and (c) artifactual (m/z 528) 3-nitrotyrosine was mon-
itored simultaneously using selected ion monitoring in the negative ion electron capture mode.
Figure 4
Immunohistochemical staining of wild-type and
myeloperoxidase-deficient neutrophils for 3-nitrotyrosine
(red immunostaining; a–c) or inducible nitric oxide syn-
thase (iNOS) (brown immunostaining; d–f). Cells were
incubated with K. pneumoniae in the presence (a, c, d, and
f) or absence (b and e) of NO2– and then subjected to
immunostaining.
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requires NO2–. To determine whether NO2– is available
during inflammation, levels of NO2– and NO3– were
quantified in peritoneal lavage fluid from mice sub-
jected to the two different models of inflammation.
Levels of total NO2– and NO3– were 20-fold higher in
mice injected with K. pneumoniae than in mice sub-
jected to CLP (Figure 7). Levels of total NO2– and
NO3– were similar in sham-operated mice and mice
subjected to CLP (data not shown). There was no sig-
nificant difference in the levels of total NO2– and
NO3– between the wild-type mice and myeloperoxi-
dase-deficient mice in either model. These observa-
tions strongly suggest that myeloperoxidase requires
elevated levels of NO• or products derived from NO•
to produce reactive nitrogen species in vivo.
Discussion
More than 40 years ago, Chance demonstrated that
NO2– can serve as a substrate for peroxidases (36). More-
over, nitrating oxidants are implicated in host defense
mechanisms and the pathogenesis of many diseases (1,
3, 5). Recent studies show that myeloperoxidase and
other peroxidases use H2O2 and NO2– to nitrate tyrosine
in vitro (15–18, 37), leading to the proposal that perox-
idases contribute to the generation of reactive nitrogen
species and inflammation in vivo. However, it is not yet
established whether peroxidases are physiologically rel-
evant sources of nitrating oxidants.
To determine whether myeloperoxidase nitrates tyro-
sine in vivo, we used isotope dilution GC/MS to quanti-
fy 3-nitrotyrosine levels in lavage fluid from septic mice,
using two models of acute peritoneal inflammation. We
found that, after infection with K. pneumoniae, wild-type
mice had markedly higher levels of free 3-nitrotyrosine
than did myeloperoxidase-deficient mice. After CLP,
however, wild-type and myeloperoxidase-deficient mice
had comparable levels of the nitrated amino acid.
Although both models of intraabdominal inflamma-
tion were characterized by an intense neutrophil
response and a marked increase in levels of 3-chloroty-
rosine, a marker of myeloperoxidase action, they differed
in one important respect. Levels of total NO2– and NO3–
were 20-fold higher in mice injected with K. pneumoniae
than in mice subjected to CLP. These results indicate
that myeloperoxidase generates oxidants that can
nitrate tyrosine after mice are infected with K. pneumo-
niae. They also suggest that the enzyme generates these
oxidants only under conditions associated with marked
increases in NO2– and NO3–. Our observations strongly
support the proposal that myeloperoxidase uses NO2–
or other NO•-derived species to produce inflammatory
nitrating oxidants in vivo.
3-Nitrotyrosine was detectable in myeloperoxidase-
deficient mice, indicating that pathways independent
of the enzyme contribute to 3-nitrotyrosine formation
in vivo. Potential mechanisms include uptake of 
3-nitrotyrosine from the gastrointestinal track (per-
haps generated by the interaction of NO2– and tyrosine
in the acidic milieu of the stomach) (38), reactive nitro-
gen species generated by other peroxidases such as
eosinophil peroxidase (37), and ONOO– derived from
the interaction of superoxide and NO• (4, 5). It is inter-
esting to note that myeloperoxidase-deficient mice
injected with K. pneumoniae increased their levels of
total NO2– and NO3– 20-fold but failed to demonstrate
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Figure 6
Quantification of (a) free 3-chlorotyrosine and (b) free 3-nitrotyrosine
in peritoneal fluid isolated from wild-type and myeloperoxidase-defi-
cient mice subjected to either CLP or infection with K. pneumoniae. 
3-Chlorotyrosine (3-Cl-Tyr) and 3-nitrotyrosine (3-NO2-Tyr) were
quantified by isotope dilution GC/MS with selected ion monitoring in
negative ion electron capture mode. KP, infection with K. pneumoniae.
Figure 7
Quantification of NO2– and NO3– levels in peritoneal fluid isolated
from wild-type and myeloperoxidase-deficient mice subjected to
either CLP or infection with K. pneumoniae. Total NO2– and NO3– in
peritoneal lavage fluid was quantified using the Griess reagent.
Downloaded on June  3, 2013.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/15021
any increase in 3-nitrotyrosine. These observations
strongly suggest that all of the excess 3-nitrotyrosine
generated in the K. pneumoniae model of inflammation
is myeloperoxidase-dependent, even though infection
with this bacterium markedly increases the production
of NO•, which can be converted into ONOO–.
Myeloperoxidase is secreted both extracellularly and
into the phagolysosome, suggesting that it might gen-
erate reactive nitrogen species in either environment.
The immunochemical detection of 3-nitrotyrosine in
bacteria ingested by cytokine-treated human neu-
trophils suggests that the enzyme might nitrate in the
phagolysosome (35). However, studies using a fluores-
cent probe failed to demonstrate that reactive nitrogen
species are generated in the phagolysosome of human
neutrophils (39). Our immunohistochemical results
suggest that mouse neutrophils can nitrate cytoplas-
mic proteins. The reaction appears optimal when phys-
iologically relevant concentrations of NO2– are provid-
ed, but we observed a readily detectable level of
nitration by wild-type mouse neutrophils even in the
absence of NO2–. In contrast, myeloperoxidase-defi-
cient mouse neutrophils were apparently unable to
nitrate cytoplasmic proteins in the presence or absence
of NO2–, indicating that protein nitration in this sys-
tem was completely dependent upon myeloperoxidase.
At least two factors might contribute to the discrep-
ancy between the immunohistochemical and chemical
studies. First, immunohistochemistry might be more
sensitive than HPLC for detecting 3-nitrotyrosine. It is
also possible that the antibodies used for the immuno-
histochemical studies react with a molecule that is struc-
turally distinct from 3-nitrotyrosine. Second, mouse and
human neutrophils might differ in their ability to exe-
cute nitration reactions intracellularly or in the
phagolysosome (1). One particularly important factor
might be the much higher levels of inducible nitric oxide
synthase in mouse neutrophils than in human neu-
trophils (40–42). These observations suggest that the
myeloperoxidase system of mouse neutrophils uses at
least two pathways to generate reactive nitrogen species.
One involves exogenous NO2– and/or other species
derived from NO•, and the other involves products
derived from inducible nitric oxide synthase in the neu-
trophil itself. Because human neutrophils contain very
low levels of inducible nitric oxide synthase (40–42), they
are unlikely to generate reactive nitrogen species intra-
cellularly or in the phagolysosome (39). Instead, human
neutrophils are likely to rely on NO2– from other sources
to generate nitrating oxidants in the extracellular envi-
ronment. The inflammatory milieu provides all of the
factors — numerous phagocytes and a high local con-
centration of NO• — necessary for the generation of
nitrating oxidants by myeloperoxidase (1).
A key question is whether reactive nitrogen species
generated by myeloperoxidase promote tissue damage.
For example, enzymatically active myeloperoxidase is
present in human atherosclerotic lesions, and 
3-nitrotyrosine has been detected in LDL isolated from
this tissue (43, 44). Reactive nitrogen species produced
by myeloperoxidase peroxidize the lipid moieties of
LDL in vitro, converting the lipoprotein to a form that
is recognized by the macrophage scavenger receptor
(29, 45). Unregulated uptake of such modified lipopro-
tein may play a role in cholesterol accumulation by
macrophages, a critical early step in atherogenesis (45).
The detection of elevated levels of 3-nitrotyrosine and
3-chlorotyrosine in LDL isolated from atherosclerotic
lesions suggest that reactive intermediates derived from
myeloperoxidase may indeed promote atherosclerotic
vascular disease (43, 44, 46).
Reactive nitrogen species produced by phagocytic
white blood cells might also play a key role in host
defense mechanisms by interacting with bacterial pro-
teins, disabling them, and causing dysfunction of the
bacterium (1). In a mouse model of Gram-negative
pneumonia, products derived from nitric oxide syn-
thase play a critical role in killing K. pneumoniae (47).
We found that NO2– enables myeloperoxidase to kill K.
pneumoniae efficiently at neutral pH, and we have
recently shown that neutrophils use myeloperoxidase
to generate antimicrobial chlorinating and brominat-
ing intermediates in vivo (23), raising the possibility
that reactive nitrogen species also promote bacterial
killing. An important unresolved issue is the identity of
the cellular machinery targeted for damage during
oxidative bacterial killing. To approach this issue, we
used immunoprecipitation coupled with mass spec-
trometry to identify bacterial proteins targeted for
nitration by the myeloperoxidase-H2O2-NO2– system in
vitro. Our results revealed one susceptible protein; its
sequence showed similarities to a bacterial metallopro-
teinase. Interestingly, metalloproteinases produced by
pathogenic microorganisms might be toxic to hosts
(48). In future studies, it will be important to identify
other bacterial targets for nitration, to investigate the
physiologic function of the metalloproteinase-like pro-
tein that we identified, and to determine whether nitra-
tion of bacterial proteins by myeloperoxidase might
impair the pathogenicity of K. pneumoniae.
In summary, our results show that myeloperoxidase
secreted by neutrophils generates 3-nitrotyrosine dur-
ing acute inflammation under conditions where extra-
cellular levels of NO2– and NO3– increase markedly.
One mechanism might involve direct oxidation of
NO2– to NO2•. Because NO2– enables myeloperoxidase
to kill K. pneumoniae efficiently at neutral pH, this sys-
tem might represent a novel host defense mechanism.
Moreover, elevated levels of 3-nitrotyrosine have been
detected in many acute and chronic human inflamma-
tory diseases. We have recently shown that neutrophils
employ the myeloperoxidase system to chlorinate tyro-
sine residues in vivo (23). Levels of myeloperoxidase, 
3-nitrotyrosine, and 3-chlorotyrosine are elevated in
human atherosclerotic tissue (43, 44, 46). Therefore,
reactive nitrogen species produced by myeloperoxidase
might also play a role in inflammatory tissue injury
and the pathogenesis of human disease.
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